Skip to main content
. 2021 Nov 12;35(3):256–263. doi: 10.1093/ajh/hpab175

Table 2.

Associations between high 1-year discount rate and low medication adherence (n = 235)

Low K-Wood-MAS-4 adherence (score ≥ 1)
Unadjusted
PR (95% CI)
Model 1
PR (95% CI)
Model 2
PR (95% CI)
Model 3
PR (95% CI)
High 1-year discount rate 1.67***
(1.28, 2.17)
1.56**
(1.18, 2.06)
1.63***
(1.22, 2.16)
1.58**
(1.18, 2.12)
Age 0.98
(0.96, 1.00)
0.98
(0.96, 1.00)
0.98
(0.96, 1.00)
Female 0.93
(0.73, 1.19)
0.88
(0.68, 1.14)
0.93
(0.72, 1.21)
Black race 1.29
(0.99, 1.69)
1.39*
(1.06, 1.82)
1.36*
(1.03, 1.79)
Married 1.02
(0.80, 1.30)
0.99
(0.77, 1.27)
1.00
(0.78, 1.28)
Greater than high school education 1.28
(0.93, 1.75)
1.40*
(1.02, 1.92)
1.29
(0.95, 1.76)
Hypertension diagnosed ≥10 years ago 1.03
(0.78, 1.36)
0.99
(0.75, 1.31)
Body mass index 0.99
(0.97, 1.01)
0.99
(0.97, 1.01)
≥6 medications per day 1.01
(0.77, 1.33)
0.96
(0.74, 1.26)
≥1 cardiometabolic comorbidity 0.88
(0.66, 1.17)
0.94
(0.71, 1.25)
Depressive symptoms 1.61**
(1.21, 2.14)
1.45*
(1.05, 2.01)
Low trust in healthcare provider 1.05
(0.82, 1.34)
High concerns beliefs about medications 1.12
(0.86, 1.45)
Low medication-taking self-efficacy 1.17
(0.89, 1.55)

Model 1 adjusted for age, sex, race, marital status, and education. Model 2 adjusted for covariates in Model 1 plus hypertension duration, body mass index, medication burden, cardiometabolic comorbidities, and depressive symptoms. Model 3 adjusted for covariates in Model 2 plus trust in healthcare provider, beliefs about medications, and medication-taking self-efficacy. Abbreviations: CI, confidence interval; K-Wood-MAS-4, 4-item Krousel-Wood Medication Adherence Scale; PR, prevalence ratio.

*P < 0.05, **P < 0.01, ***P < 0.001.